Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Krones

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Case Reports in Oncology|February 13, 2018
Downgrading of a G3 Neuroendocrine Tumor to a G2 Tumor: Can First-Line Cytotoxic Chemotherapy Change the Tumor Biology?Andreas Blesl, Elisabeth Krones, Marion J Pollheimer, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 22, 2017
Genetic loss of the muscarinic M<sub>3</sub> receptor markedly alters bile formation and cholestatic liver injury in miceFranziska Durchschein, Elisabeth Krones, Marion J Pollheimer, et al.
Journal of Hepatology|February 2, 2013
Differential effects of norUDCA and UDCA in obstructive cholestasis in micePeter Fickert, Marion J Pollheimer, Dagmar Silbert, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 161: A 42-year-old journalist with fatigue, elevated liver function tests, hyperglycemia and pruritusElisabeth Fabian, Markus Peck-Radosavljevic, Elisabeth Krones, et al.
Nutrients|June 27, 2020
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated CirrhosisAngela Horvath, Marija Durdevic, Bettina Leber, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
BMC Nephrology|December 3, 2015
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosisElisabeth Krones, Peter Fickert, Sabine Zitta, et al.
Journal of Hepatology|November 4, 2015
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitisAnna Baghdasaryan, Claudia D Fuchs, Christoph H Österreicher, et al.
Arthritis Research & Therapy|October 26, 2017
Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathyChristian Dejaco, Andreas Stadlmayr, Christina Duftner, et al.
Journal of Hepatology|February 1, 2020
FXR-dependent Rubicon induction impairs autophagy in models of human cholestasisKatrin Panzitt, Emilian Jungwirth, Elisabeth Krones, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Case Reports in Oncology|February 13, 2018
Downgrading of a G3 Neuroendocrine Tumor to a G2 Tumor: Can First-Line Cytotoxic Chemotherapy Change the Tumor Biology?Andreas Blesl, Elisabeth Krones, Marion J Pollheimer, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 22, 2017
Genetic loss of the muscarinic M<sub>3</sub> receptor markedly alters bile formation and cholestatic liver injury in miceFranziska Durchschein, Elisabeth Krones, Marion J Pollheimer, et al.
Journal of Hepatology|February 2, 2013
Differential effects of norUDCA and UDCA in obstructive cholestasis in micePeter Fickert, Marion J Pollheimer, Dagmar Silbert, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 161: A 42-year-old journalist with fatigue, elevated liver function tests, hyperglycemia and pruritusElisabeth Fabian, Markus Peck-Radosavljevic, Elisabeth Krones, et al.
Nutrients|June 27, 2020
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated CirrhosisAngela Horvath, Marija Durdevic, Bettina Leber, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
BMC Nephrology|December 3, 2015
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosisElisabeth Krones, Peter Fickert, Sabine Zitta, et al.
Journal of Hepatology|November 4, 2015
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitisAnna Baghdasaryan, Claudia D Fuchs, Christoph H Österreicher, et al.
Arthritis Research & Therapy|October 26, 2017
Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathyChristian Dejaco, Andreas Stadlmayr, Christina Duftner, et al.
Journal of Hepatology|February 1, 2020
FXR-dependent Rubicon induction impairs autophagy in models of human cholestasisKatrin Panzitt, Emilian Jungwirth, Elisabeth Krones, et al.
Pageof 3